The Rx Consultant
 

Keeping health professionals current with useful, quick updates on drugs & therapy - with CE for pharmacists, pharmacy technicians and advanced practice RNs.

Your
Subscription to
The Rx Consultant
Includes:
  • Save Time  | 
  • Stay Current  | 
  • Get CE

Learn what's new with top-selling drugs and common health conditions, & get a quick review. Articles provide context and background in addition to the core information you will use every day.

Meet your state CE requirements and maintain/expand your expertise. 1-2 hours of CE in every issue. Always independently researched & written, with no drug industry money or bias.

Stay up-to-date on the news that matters most & always have answers to key questions at hand.

Quickly check your facts, verify a dose, or give a quick answer with our popular reference cards.

Get the top takeaways from every issue of The Rx Consultant - for an instant update or a quick refresher

Sharpen your patient counseling skills with expert answers to common questions & key counseling points.

Stay ahead of the curve with at-a-glance updates on drugs, doses, common side effects & interactions, indications, treatment guidelines, and more.

50+ hours of current CE on the topics pharmacists, nurse practitioners and pharmacy technicians need to stay current. Get the CE you need today.

 

We do the research, distill the results, consult the experts, and check every fact - so you don't have to.

 
Free Trial Subscription - Includes CE
  • Sign up now & get:
  1. Free Access to CE Programs
  2. Selected Patient Q&A Bulletins
  3. Email Alerts - Latest Healthcare News
  4. Exclusive Offers & Discounts
Sign up now!
Look Up CE Requirements by State
 
 
Popular CE Programs
 

2.0  Hours of CE for Pharmacists Advanced Practice RNs & Pharmacy Technicians.

2.0 Hours of ACPE approved CE. Pharmacists, Advanced Practice RNs & Pharmacy Technicians.

1.5 Hours of ACPE approved CE. Pharmacists, Advanced Practice RNs & Pharmacy Technicians.

Our Clients
"The Rx Consultant definitely saves me time. It has the information I need in an easy-to-read format." - W.Gardner
  • New Triple Antibiotic
    Addressing antibiotic-resistant infections is a key public health challenge. The FDA has approve... Read More
  • Revisiting CBD Drug Interactions
    The May issue of The Rx Consultant focused on cannabidiol (CBD) and included a brief summary of d... Read More
  • Statins May Lower Glaucoma Risk
    Statins have an established role in the prevention and treatment of cardiovascular (CV) disease.... Read More
  • Sunscreen Absorption
    When used as directed, are sunscreen ingredients absorbed? The FDA waives toxicity testing on s... Read More
  • Naloxone From Pharmacists Reduces Opioid Deaths
    Allowing pharmacists to dispense naloxone without a prescription reduces fatal opioid-related o... Read More
  • Tegaserod Reapproved
    Tegaserod (ZelnormTM), initially approved by the FDA in 2002, was voluntarily removed from the ma... Read More
  • Cardiovascular disease (CVD), which includes high blood pressure, stroke, heart failure, and coronary heart disease, is prevalent and costly. Coronary heart disease is the most common form, accounting for 43% of all deaths attributed to CVD. The underlying pathophysiology of CVD is atherosclerosis; hence the term atherosclerotic cardiovascular disease (ASCVD). Risk factor management and treatment are essential to prevent CVD progression, cardiovascular events, and costly healthcare. It is important for both prescribers and pharmacists to educate patients about a heart healthy lifestyle and promote adherence to drug therapy to prevent disease progression and lower the costs associated with CVD.

    In November 2018, the American College of Cardiology and the American Heart Association (ACC/AHA) cholesterol guideline was published online. The writing committee included physicians from several specialty areas, pharmacists, a nurse practitioner, a physician assistant, and a layperson. In addition to the ACC/AHA, the writing committee included representatives from 10 other national organizations. The guideline provides an evidence-based and patient-centered approach to the assessment and treatment of ASCVD. The 2018 guideline builds on many of the concepts introduced in the 2013 ACC/AHA cholesterol guideline, including the emphasis on using a high or moderate-intensity statin as first-line therapy based on patient risk, the use of the 10-year ASCVD risk estimator for certain patients, measuring lipids to monitor response to therapy and adherence, and the patient-clinician discussion...


  • This issue highlights the use of continuous glucose monitoring (CGM) systems, sodium glucose transport protein-2 (SGLT2) inhibitors, newer insulin formulations, and the expert guideline recommendations focused on individualization of therapy.

    In 2017, the Centers for Disease Control reported that over 30 million people in the US (~10% of the population) have diabetes, including 7.2 million who are undiagnosed. The total estimated cost of diagnosed diabetes in the US was $327 billion in 2017.2 Individuals with diabetes incur average annual medical expenses of about $16,750 – more than twice the expense for people without diabetes.

    Over the last decade, the options for managing diabetes have grown dramatically – including new medication classes (eg, glucagon- like peptide-1 agonists, sodium-glucose transport protein-2 inhibitors), new insulin analogs (eg, insulin degludec, biosimilar insulins), and new technologies to help patients monitor their diabetes (eg, continuous glucose monitoring).

    Clinical practice guidelines have increased the emphasis on individualizing treatment options and goals to meet the needs of each patient. Patients have more say in the management of their diabetes and overall health. It is essential that healthcare providers help patients navigate the vast pool of information available at their fingertips. Diabetes patients can easily get confused by the often-conflicting information or misinformation available on television and the internet, and from friends and family members. Community providers need a good, working knowledge of patient-specific diabetes management, including current treatments and technologies...

 
ACPE logo

Pharmacists: Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Advanced Practice Nurses : (Nurse Practitioners and Clinical Nurse Specialists): CE hours provided by Continuing Education Network (in The Rx Consultant) meet the ANCC criteria and the AANP criteria for formally approved continuing education hours. Click here for more information about the ANCC criteria. Click here for more information about the AANP criteria.

Registered Nurses : Click here for specific information on acceptance of CE from The Rx Consultant by your state Board of Registered Nursing.